Public-registry site landscape for NCT03326674, a Breast Cancer study sponsored by Odonate Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT03326674 (registry record) |
| Sponsor | Odonate Therapeutics, Inc. |
| Condition(s) | Breast Cancer |
| Phase | PHASE3 |
| Listed sites | 207 |
| Site countries | United States, Australia, Austria, Belgium, Canada, Czechia, France, Germany, Hungary, Italy, Poland, Russia |
Eichor generates a preliminary site-risk snapshot for NCT03326674 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →